ECOR Stock Analysis: Buy, Sell, or Hold?
ECOR - electroCore, Inc. Common Stock
$6.80
0.25 (3.82%)
▲
5d:
-13.71%
30d:
+49.45%
90d:
+34.92%
WAIT
LOW Confidence
Last Updated: February 2, 2026
Earnings: Mar 11, 2026
Get Alerted When ECOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ECOR is down 13.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ECOR is down 13.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ECOR is currently trading at $6.80, which is considered slightly high relative to its 30-day fair value range of $5.04 to $7.34.
Technical Outlook: Technically, ECOR is in a uptrend. Immediate support is located at $6.40, while resistance sits at $8.30. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.75 (+201.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ECOR is in a uptrend. Immediate support is located at $6.40, while resistance sits at $8.30. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.75 (+201.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$5.04 -
$7.34
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BULLISH: Trading 201.5% below Wall St target ($19.75)
- WARNING: Recommendation downgraded due to -13.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$5.04 -
$7.34
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$6.40
Resistance Level
$8.30
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-5.30
Wall Street Target
$19.75
(+201.5%)
Revenue Growth (YoY)
32.6%
Profit Margin
-47.5%
Last updated: February 03, 2026 9:51 AM ET
Data refreshes hourly during market hours. Next update: 10:51 AM
Data refreshes hourly during market hours. Next update: 10:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ECOR showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Daniel S Goldberger
BUY
1000 shares
2025-08-11
Thomas J Errico
BUY
15000 shares
2025-08-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 66 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 59 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 57 HOLD |
